LJPC

La Jolla Pharmaceutical Company

Healthcare

Set alert

Price alert · LJPC

All alert types
6.19 0.00 0.00%
As of Aug 15, 2022
6.19 Day range 6.22

52-week range unavailable

Open
6.20
Prev close
6.19
Mkt cap
155.11M
Vol
960.93K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
6.19
High
6.22
Forward P/E
27.04
Beta
2.41
Short ratio
0.20
Inst. own
70.85%
Dividend
0.00
Ex-div date
Earnings
Aug 15, 2022
50-d avg
5.11
200-d avg
4.46
1y target
6.23

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for LJPC has not been loaded yet. Try again in a moment.

Valuation

P/E 8.0×
FY 2012: -0.2×FY 2013: -0.2×FY 2014: -9.2×FY 2015: -10.1×FY 2016: -3.9×FY 2017: -5.9×FY 2018: -1.2×FY 2019: -0.9×FY 2020: -2.7×FY 2021: 8.0×
FY 2012 5y median -1.2× FY 2021
P/S 2.1×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 400×FY 2016: 490×FY 2017: 0.0×FY 2018: 23.8×FY 2019: 4.6×FY 2020: 3.2×FY 2021: 2.1×
FY 2012 5y median 3.2× FY 2021
P/B -2.4×
FY 2012: 0.5×FY 2013: 0.5×FY 2014: 4.1×FY 2015: 3.4×FY 2016: 4.9×FY 2017: 7.7×FY 2018: 6.7×FY 2019: -1.9×FY 2020: -1.2×FY 2021: -2.4×
FY 2012 5y median -1.2× FY 2021
P/FCF 5.6×
FY 2012: -0.8×FY 2013: -0.8×FY 2014: -15.0×FY 2015: -15.7×FY 2016: -5.0×FY 2017: -7.3×FY 2018: -1.5×FY 2019: -1.2×FY 2020: -2.8×FY 2021: 5.6×
FY 2012 5y median -1.5× FY 2021
EV/EBITDA 3.6×
FY 2012: 0.2×FY 2013: 0.3×FY 2014: -6.9×FY 2015: -7.1×FY 2016: -3.0×FY 2017: -5.1×FY 2018: -0.4×FY 2019: -0.5×FY 2020: -3.4×FY 2021: 3.6×
FY 2012 5y median -0.5× FY 2021
EV/Sales 1.5×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 280×FY 2016: 384×FY 2017: 0.0×FY 2018: 6.7×FY 2019: 2.1×FY 2020: 2.6×FY 2021: 1.5×
FY 2012 5y median 2.1× FY 2021
FCF Yield 17.8%
FY 2012: -129.3%FY 2013: -129.8%FY 2014: -6.7%FY 2015: -6.4%FY 2016: -20.2%FY 2017: -13.8%FY 2018: -64.5%FY 2019: -80.4%FY 2020: -35.5%FY 2021: 17.8%
FY 2012 5y median -35.5% FY 2021

Profitability

Gross Margin 82.2%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 100.0%FY 2016: 100.0%FY 2017: 0.0%FY 2018: 83.7%FY 2019: 89.6%FY 2020: 76.6%FY 2021: 82.2%
FY 2012 5y median 82.2% FY 2021
Operating Margin 28.8%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: -3970.6%FY 2016: -12722.7%FY 2017: 0.0%FY 2018: -1929.7%FY 2019: -476.3%FY 2020: -107.2%FY 2021: 28.8%
FY 2012 5y median -107.2% FY 2021
Net Margin 26.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: -3965.2%FY 2016: -12692.4%FY 2017: 0.0%FY 2018: -1983.6%FY 2019: -505.4%FY 2020: -118.0%FY 2021: 26.0%
FY 2012 5y median -118.0% FY 2021
ROE -29.5%
FY 2012: -240.7%FY 2013: -234.4%FY 2014: -44.0%FY 2015: -33.7%FY 2016: -128.1%FY 2017: -130.2%FY 2018: -555.3%FY 2019: 208.1%FY 2020: 44.8%FY 2021: -29.5%
FY 2012 5y median -29.5% FY 2021
ROIC 25.3%
FY 2012: -334.1%FY 2013: -234.4%FY 2014: -44.0%FY 2015: -33.7%FY 2016: -128.4%FY 2017: -114.3%FY 2018: -111.6%FY 2019: -99.4%FY 2020: -59.6%FY 2021: 25.3%
FY 2012 5y median -99.4% FY 2021
ROA 19.4%
FY 2012: -225.6%FY 2013: -205.0%FY 2014: -42.2%FY 2015: -32.4%FY 2016: -110.4%FY 2017: -96.0%FY 2018: -97.6%FY 2019: -88.1%FY 2020: -54.6%FY 2021: 19.4%
FY 2012 5y median -88.1% FY 2021

Growth (YoY)

Revenue 126.6%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: -41.7%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 129.3%FY 2020: 45.0%FY 2021: 126.6%
FY 2012 FY 2021
Operating Income 160.9%
FY 2012: -372.3%FY 2013: -67.0%FY 2014: -19.0%FY 2015: -96.7%FY 2016: -86.7%FY 2017: -47.3%FY 2018: -68.1%FY 2019: 43.4%FY 2020: 67.4%FY 2021: 160.9%
FY 2012 FY 2021
EPS (diluted) 140.3%
FY 2012: 97.6%FY 2013: -4.1%FY 2014: 94.9%FY 2015: -34.0%FY 2016: -69.4%FY 2017: -19.2%FY 2018: -45.1%FY 2019: 45.2%FY 2020: 66.5%FY 2021: 140.3%
FY 2012 FY 2021
Free Cash Flow 175.0%
FY 2012: -16.9%FY 2013: -123.7%FY 2014: -175.0%FY 2015: -105.5%FY 2016: -125.5%FY 2017: -54.5%FY 2018: -64.5%FY 2019: 44.6%FY 2020: 56.1%FY 2021: 175.0%
FY 2012 FY 2021

Financial Health

Current Ratio 3.8×
FY 2012: 15.9×FY 2013: 8.0×FY 2014: 24.2×FY 2015: 26.5×FY 2016: 6.9×FY 2017: 5.1×FY 2018: 6.0×FY 2019: 4.0×FY 2020: 3.0×FY 2021: 3.8×
FY 2012 5y median 4.0× FY 2021
Quick Ratio 3.5×
FY 2012: 15.9×FY 2013: 8.0×FY 2014: 24.2×FY 2015: 26.5×FY 2016: 6.9×FY 2017: 5.1×FY 2018: 5.9×FY 2019: 3.9×FY 2020: 2.5×FY 2021: 3.5×
FY 2012 5y median 3.9× FY 2021
Debt / Equity -0.0×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.5×FY 2020: -0.0×FY 2021: -0.0×
FY 2012 5y median -0.0× FY 2021
Net Debt / EBITDA -1.4×
FY 2012: 0.4×FY 2013: 0.5×FY 2014: 2.3×FY 2015: 3.0×FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.9×FY 2019: 0.6×FY 2020: 0.8×FY 2021: -1.4×
FY 2012 5y median 0.8× FY 2021
Interest Coverage 2.1×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -26.6×FY 2019: -10.2×FY 2020: -3.6×FY 2021: 2.1×
FY 2012 5y median -3.6× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31